Nanoveu Ltd. · ASX:NVU
Nanoveu — Investor Presentation (November 2021)
13 slides from Nanoveu's investor presentation, Nov 18, 2021
Slide 1: ASX Release: Broker Briefing Investor Webinar Presentation
Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 +61 8 6244 9095 www.nanoveu.com For personal use only ASX RELEASE 18 November 2021 ASX: NVU Broker Briefing Investor Webinar Presentation Nanoveu Limited (“Nanoveu”) participated in a Broker Briefing Investor Webinar on Thursday 18 November 2021 at
Slide 2: Broker Briefing 18 November 2021
For personal use only (ASX:NVU) Cutting-edge antiviral nanotechnology reducing contagious transmissions on high touch points BROKER BRIEFING 18 NOVEMBER 2021
Slide 3: Disclosure and Disclaimer
DISCLOSURE AND DISCLAIMER For personal use only The information in this presentation has been prepared by Nanoveu for the purposes of providing an overview of the company and its products. This presentation does not constitute investment advice. Neither does this presentation nor the information con
Slide 4: Company Snapshot
COMPANY SNAPSHOT For personal use only • Nanoveu is an ASX microcap innovative tech solution company • Developed a suite of technologies and products to protect against COVID-19/SARS 2CoV1 • With these developments, Nanoveu are leading a new world of antiviral self disinfectants Shareholder Breakdow
Slide 5: Product Development Timeline
PRODUCT DEVELOPMENT TIMELINE For personal use only 2017 2020 2021 2022 EyeFly3D phone screen protector Nanoshield™ developed and CustomSkins lamination machines Designed to correct the output launched with the ability to produce 3D launched in early 2020, with have been manufactured in China, from d
Slide 6: The Self Disinfectant Market
THE SELF DISINFECTANT MARKET For personal use only Estimated Global Forecast Global Growing at a Forecast Antimicrobial Antimicrobial Compounded Annual Coatings Market Size Coatings Market Size Growth Rate $8.1b $53.5b 13.1% In 2020 In 2028 https://www.grandviewresearch.com/industry-analysis/antimic
Slide 7: Nanoveu Products Address the Market's Needs
NANOVEU PRODUCTS ADDRESS THE MARKET’S NEEDS For personal use only NanishieldTM sprays would perform better than quaternary ammonium salts and solutions NanoshieldTM PET, PVC films would be an effective and NanoshieldTM PVC films safe solution would reduce bacterial and for electronic viral activity
Slide 8: Distribution
DISTRIBUTION NanoshieldTM Distributors and Joint Ventures and Sales Networks For personal use only United Kingdom United States Singapore Australia Exclusive distributors: AUSTRALIA - Touch Guard Pty Ltd PHILIPPINES – Avolution Inc. MALAYSIA - Singapore Sanyo Trading Pte Ltd THAILAND - Singapore San
Slide 9: Flagship Direct Customer
FLAGSHIP DIRECT CUSTOMER Providing Validation from a Tier-1 Global Company For personal use only ¡ From June 2020, Nestlé Research undertook thorough performance evaluation of Nanoshield in their Switzerland laboratories, with peer reviewed findings published in science journals in May 2021 ¡ Nanove
Slide 10: Nanoshield for Armaguard
NANOSHIELDTM FOR ARMAGUARD Providing Antiviral Protection For personal use only ¡ Nanoveu’s Australian distributor High Touch is helping keep Australians safe with a range of Nanoshield films. ¡ High Touch’s agreement for Nanoshield antiviral surface protection for Armaguard’s extensive network of A
Slide 11: Our Team
OUR TEAM For personal use only Scott Beeton Alfred Chong Steven Apedaile David Nicol Micheal van Uffelen Chairman CH Managing Director Non-Executive Non-Executive Executive Director, CFO and CEO Director Director and Company Secretary 10 JULIANA THOMAS NAN DAR NORIN RUIFENG LIN GIM HAN LAW ELIZA NG
Slide 12: Where We Are Heading
WHERE WE ARE HEADING For personal use only New Products Grow Sales Lead the Trend Identifying new products to serve the needs of our customers Continue building direct Fulfil regulatory obligations and lead trend in self flagship sales channels disinfectant surface coatings 11
Slide 13: Contact
CONTACT For personal use only Alfred Chong Managing Director and CEO t: +65 6557 0155 e: [email protected] Jane Morgan Investor Relations t: 0405 555 618 e: [email protected] 12